No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Apoptosis / drug effects*
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Dose-Response Relationship, Drug
-
Drug Synergism
-
Humans
-
Immunologic Factors / administration & dosage
-
Immunologic Factors / pharmacology
-
Multiple Myeloma / drug therapy
-
Multiple Myeloma / pathology*
-
Oligopeptides / administration & dosage
-
Oligopeptides / pharmacology*
-
Proteasome Inhibitors / administration & dosage
-
Proteasome Inhibitors / pharmacology
-
Thalidomide / administration & dosage
-
Thalidomide / analogs & derivatives*
-
Thalidomide / pharmacology
Substances
-
Immunologic Factors
-
Oligopeptides
-
Proteasome Inhibitors
-
Thalidomide
-
carfilzomib
-
pomalidomide